This company has been acquired
EQRx Management
Management criteria checks 2/4
EQRx's CEO is Melanie Nallicheri, appointed in Sep 2021, has a tenure of 2.17 years. total yearly compensation is $4.35M, comprised of 13.8% salary and 86.2% bonuses, including company stock and options. directly owns 1.96% of the company’s shares, worth $22.30M. The average tenure of the management team and the board of directors is 3.3 years and 2.3 years respectively.
Key information
Melanie Nallicheri
Chief executive officer
US$4.4m
Total compensation
| CEO salary percentage | 13.79% |
| CEO tenure | 2.2yrs |
| CEO ownership | 2.0% |
| Management average tenure | 3.3yrs |
| Board average tenure | 2.3yrs |
Recent management updates
Recent updates
We're Hopeful That EQRx (NASDAQ:EQRX) Will Use Its Cash Wisely
Jul 25
EQRx (NASDAQ:EQRX) Is In A Good Position To Deliver On Growth Plans
Feb 22We're Not Very Worried About EQRx's (NASDAQ:EQRX) Cash Burn Rate
Nov 08EQRx: Saving American Lives, Made Possible By Low Cost Chinese Drugs
Aug 28 EQRx GAAP EPS of -$0.17 beats by $0.03
Aug 11Here's Why We're Not Too Worried About EQRx's (NASDAQ:EQRX) Cash Burn Situation
Jul 24We Think EQRx (NASDAQ:EQRX) Can Afford To Drive Business Growth
Apr 08EQRx (NASDAQ:EQRX) Is In A Good Position To Deliver On Growth Plans
Dec 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$260m |
| Jun 30 2023 | n/a | n/a | -US$263m |
| Mar 31 2023 | n/a | n/a | -US$272m |
| Dec 31 2022 | US$4m | US$600k | -US$169m |
| Sep 30 2022 | n/a | n/a | -US$146m |
| Jun 30 2022 | n/a | n/a | -US$100m |
| Mar 31 2022 | n/a | n/a | -US$53m |
| Dec 31 2021 | US$4m | US$509k | -US$100m |
| Sep 30 2021 | n/a | n/a | -US$279m |
| Jun 30 2021 | n/a | n/a | -US$296m |
| Mar 31 2021 | n/a | n/a | -US$269m |
| Dec 31 2020 | US$771k | US$475k | -US$250m |
Compensation vs Market: Melanie's total compensation ($USD4.35M) is about average for companies of similar size in the US market ($USD3.42M).
Compensation vs Earnings: Melanie's compensation has increased whilst the company is unprofitable.
CEO
Melanie Nallicheri (54 yo)
Ms. Melanie I. Nallicheri has been Chief Executive Officer and Director of EQRx, Inc. (Former Name: CM Life Sciences III Inc.) since September 1, 2021 and President since December 2021 and is its Principal...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman of Board of Directors | 3.8yrs | no data | 3.88% $ 44.0m | |
| President | 2.2yrs | US$4.35m | 1.96% $ 22.3m | |
| General Counsel & Corporate Secretary | 1.8yrs | US$2.02m | 0.032% $ 366.8k | |
| Co-Founder & Advisor | no data | no data | no data | |
| Co-Founder & Advisor | no data | no data | no data | |
| Co-Founder & Advisor | no data | no data | no data | |
| Chief of Technical Operations | 3.3yrs | no data | no data | |
| Chief People Officer | 3.3yrs | no data | no data | |
| Chief of RX Creation | 2.3yrs | no data | no data | |
| Chief Physician Executive | 3.3yrs | US$736.87k | 0.13% $ 1.5m | |
| Physician-In-Chief | 3.7yrs | no data | no data |
Experienced Management: EQRX's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman of Board of Directors | 3.8yrs | no data | 3.88% $ 44.0m | |
| President | 2.2yrs | US$4.35m | 1.96% $ 22.3m | |
| Member of Mission Advisory Board | 2.3yrs | no data | no data | |
| Independent Director | 3.8yrs | US$372.41k | 0.13% $ 1.5m | |
| Member of Mission Advisory Board | 2.3yrs | no data | no data | |
| Member of Mission Advisory Board | 2.3yrs | no data | no data | |
| Member of Mission Advisory Board | 2.3yrs | no data | no data | |
| Co-Founder | 4.3yrs | US$475.19k | 0.097% $ 1.1m | |
| Independent Director | 3.8yrs | US$374.91k | 0% $ 0 | |
| Member of Mission Advisory Board | 2.3yrs | no data | no data | |
| Independent Director | 2.3yrs | US$750.00k | 0.041% $ 468.0k | |
| Member of Mission Advisory Board | 2.3yrs | no data | no data |
Experienced Board: EQRX's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/11/10 11:35 |
| End of Day Share Price | 2023/11/08 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
EQRx, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Chris Shibutani | Goldman Sachs |
| Akash Tewari | Jefferies LLC |
| Christopher Schott | J.P. Morgan |